Spyrson (formerly Neurolign Technologies) is the world leader in neuro-functional monitoring and eye-tracking technology. The neurological health-tech company is on a mission to create a quantum shift in the clinical approach to neurodegenerative disease while simultaneously revolutionizing the way that consumers think and care for their ongoing brain health and wellness. Spryson is driven by an overarching ethos of accessibility – making sophisticated eye-tracking equipment and brain health detection technology a viable option for a greater number of organizations and institutions, while also bringing the most widely applicable aspects of this pioneering technology into everyday homes.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Royal Bank Plaza - South Tower, 200 Bay Street,suite 2305,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- neurolign.com
- Keywords
- Diagnostics, Concussion, Neurological Disorders, Pharmaceutical, Eye Tracking, Vestibular-Ocular, General Wellness, Consumer Devices, Brain Health.
- HQ
- Toronto, ON
Spryson Questions
Spryson's website is neurolign.com
Spryson's LinkedIn profile is https://www.linkedin.com/company/spryson-ai
Spryson has
9 employees.
View email and phone details for 9
employees at Spryson.
Spryson's industry is
Medical Equipment Manufacturing
Spryson's top competitors are
Mount Sinai Hospital (Toronto), Sinai Health,
Empire Homes,
Centre For Digital Therapeutics,
Ghost Video,
Spryson,
Vector Institute,
Ka Imaging Inc.,
Mozzaz Corporation,
Cardata,
St. Michael's Hospital.
Spryson's categories are Medical Equipment Manufacturing
Spryson's founding year is 2019
